Tech Company Financing Transactions
Rodin Therapeutics Funding Round
Rodin Therapeutics closed a Seed financing round on 6/28/2013. Backers included Atlas Venture and Johnson & Johnson Development Corporation.
Transaction Overview
Company Name
Announced On
6/28/2013
Transaction Type
Venture Equity
Amount
Unknown
Round
Seed
Investors
Atlas Venture (Bruce Booth)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
300 Technology Sq. 8th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Not Recorded
Overview
Rodin is harnessing the power of epigenetic regulation of neuronal function to treat diseases of the brain. We believe modulation of selective epigenetic regulatory processes can restore synaptic plasticity and cognitive function in degenerative brain diseases, as well as to aid the brain in reducing negative associations with traumatic memories.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Bruce Booth
Chairman
Martin Jefson
Chief Executive Officer
Adam Rosenberg
Chief Medical Officer
Michael Ryan
Vice President
Magnus Ivarsson
VP - Bus. Development
Anne Sullivan
VP - Operations
Steven Sweeney
VP - R & D
Berkley Lynch
Browse more venture capital transactions:
Prev: 6/28/2013: REACH Health venture capital transaction
Next: 6/28/2013: Perlego Systems venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs